Compare Colgate-Palmolive Company (CL) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Colgate-Palmolive Company vs Zimmer Biomet Holdings Inc — how do they compare? Colgate-Palmolive Company trades at $92.31 (market cap $74.26B), while Zimmer Biomet Holdings Inc trades at $97 (market cap $18.65B). The key difference: Colgate-Palmolive Company is far larger — about 4× Zimmer Biomet Holdings Inc's market cap, and Colgate-Palmolive Company pays the higher dividend (2.28%). Which is the better fit depends on your goals.
| CL | ZBH | |
|---|---|---|
Market Cap | $74.26B | $18.65B |
Sector | Consumer Staples | Health |
52-Week High | $99.14 | $107.71 |
52-Week Low | $74.98 | $79.58 |
Enterprise Value | $80.74B | $25.72B |
Dividend Yield | 2.28% | 0.98% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
